The scored backbone above is sourced from primary filings. The full investigative dossier — claim-by-claim audit, inversion analysis, primary paper trail — is being authored. This page updates as evidence lands. No claims are fabricated or inferred here; only data the engine already holds is shown.
| ASML forward P/E ~41x | (GuruFocus, 2026-03-11: 41.2 | Verified sheet |
| Trailing P/E | elevated post-2025 run (Yaho | Verified sheet |
| Price/sales ~13–19× | (Yahoo, 2026 — med conf). Pr | Verified sheet |
| 15-yr historical ASML median P/E = NOT SOURC | — do not invent a long-run a | Verified sheet |